Treatment Algorithms for Systemic Sclerosis According to Experts.
Identifieur interne : 000C10 ( Main/Curation ); précédent : 000C09; suivant : 000C11Treatment Algorithms for Systemic Sclerosis According to Experts.
Auteurs : Andreu Fernández-Codina [Espagne] ; Kyle M. Walker [Canada] ; Janet E. Pope [Canada]Source :
- Arthritis & rheumatology (Hoboken, N.J.) [ 2326-5205 ] ; 2018.
Descripteurs français
- KwdFr :
- Acide mycophénolique (usage thérapeutique), Algorithmes, Antagonistes des récepteurs aux angiotensines (usage thérapeutique), Antagonistes des récepteurs de l'endothéline (usage thérapeutique), Anticorps monoclonaux humanisés (usage thérapeutique), Antirhumatismaux (usage thérapeutique), Arthrite (traitement médicamenteux), Arthrite (étiologie), Canaux calciques (usage thérapeutique), Cyclophosphamide (usage thérapeutique), Glucocorticoïdes (usage thérapeutique), Humains, Hydroxychloroquine, Hypertension pulmonaire (traitement médicamenteux), Hypertension pulmonaire (étiologie), Immunosuppresseurs (usage thérapeutique), Inhibiteurs de l'enzyme de conversion de l'angiotensine (usage thérapeutique), Inhibiteurs de la phosphodiestérase-5 (usage thérapeutique), Maladie de Raynaud (traitement médicamenteux), Maladie de Raynaud (étiologie), Maladies du rein (traitement médicamenteux), Maladies du rein (étiologie), Méthotrexate (usage thérapeutique), Pneumopathies interstitielles (traitement médicamenteux), Pneumopathies interstitielles (étiologie), Prostaglandines (usage thérapeutique), Rituximab (usage thérapeutique), Sclérodermie systémique (), Sclérodermie systémique (traitement médicamenteux).
- MESH :
- traitement médicamenteux : Arthrite, Hypertension pulmonaire, Maladie de Raynaud, Maladies du rein, Pneumopathies interstitielles, Sclérodermie systémique.
- usage thérapeutique : Acide mycophénolique, Antagonistes des récepteurs aux angiotensines, Antagonistes des récepteurs de l'endothéline, Anticorps monoclonaux humanisés, Antirhumatismaux, Canaux calciques, Cyclophosphamide, Glucocorticoïdes, Immunosuppresseurs, Inhibiteurs de l'enzyme de conversion de l'angiotensine, Inhibiteurs de la phosphodiestérase-5, Méthotrexate, Prostaglandines, Rituximab.
- étiologie : Arthrite, Hypertension pulmonaire, Maladie de Raynaud, Maladies du rein, Pneumopathies interstitielles.
- Algorithmes, Humains, Hydroxychloroquine, Sclérodermie systémique.
English descriptors
- KwdEn :
- Algorithms, Angiotensin Receptor Antagonists (therapeutic use), Angiotensin-Converting Enzyme Inhibitors (therapeutic use), Antibodies, Monoclonal, Humanized (therapeutic use), Antirheumatic Agents (therapeutic use), Arthritis (drug therapy), Arthritis (etiology), Calcium Channels (therapeutic use), Cyclophosphamide (therapeutic use), Endothelin Receptor Antagonists (therapeutic use), Glucocorticoids (therapeutic use), Humans, Hydroxychloroquine, Hypertension, Pulmonary (drug therapy), Hypertension, Pulmonary (etiology), Immunosuppressive Agents (therapeutic use), Kidney Diseases (drug therapy), Kidney Diseases (etiology), Lung Diseases, Interstitial (drug therapy), Lung Diseases, Interstitial (etiology), Methotrexate (therapeutic use), Mycophenolic Acid (therapeutic use), Phosphodiesterase 5 Inhibitors (therapeutic use), Prostaglandins (therapeutic use), Raynaud Disease (drug therapy), Raynaud Disease (etiology), Rituximab (therapeutic use), Scleroderma, Systemic (complications), Scleroderma, Systemic (drug therapy).
- MESH :
- chemical , therapeutic use : Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Calcium Channels, Cyclophosphamide, Endothelin Receptor Antagonists, Glucocorticoids, Immunosuppressive Agents, Methotrexate, Mycophenolic Acid, Phosphodiesterase 5 Inhibitors, Prostaglandins, Rituximab.
- complications : Scleroderma, Systemic.
- drug therapy : Arthritis, Hypertension, Pulmonary, Kidney Diseases, Lung Diseases, Interstitial, Raynaud Disease, Scleroderma, Systemic.
- etiology : Arthritis, Hypertension, Pulmonary, Kidney Diseases, Lung Diseases, Interstitial, Raynaud Disease.
- Algorithms, Humans, Hydroxychloroquine.
Abstract
There is a lack of agreement regarding treatment for many aspects of systemic sclerosis (SSc). We undertook this study to generate SSc treatment algorithms endorsed by a high percentage of SSc experts.
DOI: 10.1002/art.40560
PubMed: 29781586
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000107
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000107
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000083
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000446
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000446
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000446
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :000C10
Links to Exploration step
pubmed:29781586Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment Algorithms for Systemic Sclerosis According to Experts.</title>
<author><name sortKey="Fernandez Codina, Andreu" sort="Fernandez Codina, Andreu" uniqKey="Fernandez Codina A" first="Andreu" last="Fernández-Codina">Andreu Fernández-Codina</name>
<affiliation wicri:level="3"><nlm:affiliation>University of Western Ontario, London, Ontario, Canada, and Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>University of Western Ontario, London, Ontario, Canada, and Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Walker, Kyle M" sort="Walker, Kyle M" uniqKey="Walker K" first="Kyle M" last="Walker">Kyle M. Walker</name>
<affiliation wicri:level="1"><nlm:affiliation>The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>The Ottawa Hospital, University of Ottawa, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pope, Janet E" sort="Pope, Janet E" uniqKey="Pope J" first="Janet E" last="Pope">Janet E. Pope</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Western Ontario, London, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Western Ontario, London, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29781586</idno>
<idno type="pmid">29781586</idno>
<idno type="doi">10.1002/art.40560</idno>
<idno type="wicri:Area/PubMed/Corpus">000107</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000107</idno>
<idno type="wicri:Area/PubMed/Curation">000107</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000107</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000083</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000083</idno>
<idno type="wicri:Area/Ncbi/Merge">000446</idno>
<idno type="wicri:Area/Ncbi/Curation">000446</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000446</idno>
<idno type="wicri:Area/Main/Merge">000C10</idno>
<idno type="wicri:Area/Main/Curation">000C10</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Treatment Algorithms for Systemic Sclerosis According to Experts.</title>
<author><name sortKey="Fernandez Codina, Andreu" sort="Fernandez Codina, Andreu" uniqKey="Fernandez Codina A" first="Andreu" last="Fernández-Codina">Andreu Fernández-Codina</name>
<affiliation wicri:level="3"><nlm:affiliation>University of Western Ontario, London, Ontario, Canada, and Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>University of Western Ontario, London, Ontario, Canada, and Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Walker, Kyle M" sort="Walker, Kyle M" uniqKey="Walker K" first="Kyle M" last="Walker">Kyle M. Walker</name>
<affiliation wicri:level="1"><nlm:affiliation>The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>The Ottawa Hospital, University of Ottawa, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pope, Janet E" sort="Pope, Janet E" uniqKey="Pope J" first="Janet E" last="Pope">Janet E. Pope</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Western Ontario, London, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Western Ontario, London, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Arthritis & rheumatology (Hoboken, N.J.)</title>
<idno type="eISSN">2326-5205</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Algorithms</term>
<term>Angiotensin Receptor Antagonists (therapeutic use)</term>
<term>Angiotensin-Converting Enzyme Inhibitors (therapeutic use)</term>
<term>Antibodies, Monoclonal, Humanized (therapeutic use)</term>
<term>Antirheumatic Agents (therapeutic use)</term>
<term>Arthritis (drug therapy)</term>
<term>Arthritis (etiology)</term>
<term>Calcium Channels (therapeutic use)</term>
<term>Cyclophosphamide (therapeutic use)</term>
<term>Endothelin Receptor Antagonists (therapeutic use)</term>
<term>Glucocorticoids (therapeutic use)</term>
<term>Humans</term>
<term>Hydroxychloroquine</term>
<term>Hypertension, Pulmonary (drug therapy)</term>
<term>Hypertension, Pulmonary (etiology)</term>
<term>Immunosuppressive Agents (therapeutic use)</term>
<term>Kidney Diseases (drug therapy)</term>
<term>Kidney Diseases (etiology)</term>
<term>Lung Diseases, Interstitial (drug therapy)</term>
<term>Lung Diseases, Interstitial (etiology)</term>
<term>Methotrexate (therapeutic use)</term>
<term>Mycophenolic Acid (therapeutic use)</term>
<term>Phosphodiesterase 5 Inhibitors (therapeutic use)</term>
<term>Prostaglandins (therapeutic use)</term>
<term>Raynaud Disease (drug therapy)</term>
<term>Raynaud Disease (etiology)</term>
<term>Rituximab (therapeutic use)</term>
<term>Scleroderma, Systemic (complications)</term>
<term>Scleroderma, Systemic (drug therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acide mycophénolique (usage thérapeutique)</term>
<term>Algorithmes</term>
<term>Antagonistes des récepteurs aux angiotensines (usage thérapeutique)</term>
<term>Antagonistes des récepteurs de l'endothéline (usage thérapeutique)</term>
<term>Anticorps monoclonaux humanisés (usage thérapeutique)</term>
<term>Antirhumatismaux (usage thérapeutique)</term>
<term>Arthrite (traitement médicamenteux)</term>
<term>Arthrite (étiologie)</term>
<term>Canaux calciques (usage thérapeutique)</term>
<term>Cyclophosphamide (usage thérapeutique)</term>
<term>Glucocorticoïdes (usage thérapeutique)</term>
<term>Humains</term>
<term>Hydroxychloroquine</term>
<term>Hypertension pulmonaire (traitement médicamenteux)</term>
<term>Hypertension pulmonaire (étiologie)</term>
<term>Immunosuppresseurs (usage thérapeutique)</term>
<term>Inhibiteurs de l'enzyme de conversion de l'angiotensine (usage thérapeutique)</term>
<term>Inhibiteurs de la phosphodiestérase-5 (usage thérapeutique)</term>
<term>Maladie de Raynaud (traitement médicamenteux)</term>
<term>Maladie de Raynaud (étiologie)</term>
<term>Maladies du rein (traitement médicamenteux)</term>
<term>Maladies du rein (étiologie)</term>
<term>Méthotrexate (usage thérapeutique)</term>
<term>Pneumopathies interstitielles (traitement médicamenteux)</term>
<term>Pneumopathies interstitielles (étiologie)</term>
<term>Prostaglandines (usage thérapeutique)</term>
<term>Rituximab (usage thérapeutique)</term>
<term>Sclérodermie systémique ()</term>
<term>Sclérodermie systémique (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Angiotensin Receptor Antagonists</term>
<term>Angiotensin-Converting Enzyme Inhibitors</term>
<term>Antibodies, Monoclonal, Humanized</term>
<term>Antirheumatic Agents</term>
<term>Calcium Channels</term>
<term>Cyclophosphamide</term>
<term>Endothelin Receptor Antagonists</term>
<term>Glucocorticoids</term>
<term>Immunosuppressive Agents</term>
<term>Methotrexate</term>
<term>Mycophenolic Acid</term>
<term>Phosphodiesterase 5 Inhibitors</term>
<term>Prostaglandins</term>
<term>Rituximab</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Scleroderma, Systemic</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Arthritis</term>
<term>Hypertension, Pulmonary</term>
<term>Kidney Diseases</term>
<term>Lung Diseases, Interstitial</term>
<term>Raynaud Disease</term>
<term>Scleroderma, Systemic</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Arthritis</term>
<term>Hypertension, Pulmonary</term>
<term>Kidney Diseases</term>
<term>Lung Diseases, Interstitial</term>
<term>Raynaud Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Arthrite</term>
<term>Hypertension pulmonaire</term>
<term>Maladie de Raynaud</term>
<term>Maladies du rein</term>
<term>Pneumopathies interstitielles</term>
<term>Sclérodermie systémique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Acide mycophénolique</term>
<term>Antagonistes des récepteurs aux angiotensines</term>
<term>Antagonistes des récepteurs de l'endothéline</term>
<term>Anticorps monoclonaux humanisés</term>
<term>Antirhumatismaux</term>
<term>Canaux calciques</term>
<term>Cyclophosphamide</term>
<term>Glucocorticoïdes</term>
<term>Immunosuppresseurs</term>
<term>Inhibiteurs de l'enzyme de conversion de l'angiotensine</term>
<term>Inhibiteurs de la phosphodiestérase-5</term>
<term>Méthotrexate</term>
<term>Prostaglandines</term>
<term>Rituximab</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Arthrite</term>
<term>Hypertension pulmonaire</term>
<term>Maladie de Raynaud</term>
<term>Maladies du rein</term>
<term>Pneumopathies interstitielles</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Algorithms</term>
<term>Humans</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Algorithmes</term>
<term>Humains</term>
<term>Hydroxychloroquine</term>
<term>Sclérodermie systémique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">There is a lack of agreement regarding treatment for many aspects of systemic sclerosis (SSc). We undertook this study to generate SSc treatment algorithms endorsed by a high percentage of SSc experts.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C10 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000C10 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Curation |type= RBID |clé= pubmed:29781586 |texte= Treatment Algorithms for Systemic Sclerosis According to Experts. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:29781586" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ChloroquineV1
This area was generated with Dilib version V0.6.33. |